These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2457072

  • 1. In vivo and in vitro studies of microsphere pancreatic supplements.
    Littlewood JM, Kelleher J, Walters MP, Johnson AW.
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N, Santini B, Sarchi C.
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB, Escobar LC, Lees HR, Akroyd RM, Reilly HC.
    N Z Med J; 1992 Mar 25; 105(930):107-8. PubMed ID: 1553114
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pancreatin preparations used in the treatment of cystic fibrosis--lipase content and in vitro release.
    Walters MP, Littlewood JM.
    Aliment Pharmacol Ther; 1996 Jun 25; 10(3):433-40. PubMed ID: 8791974
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Two enteric coated microspheres in cystic fibrosis.
    Williams J, MacDonald A, Weller PH, Fields J, Pandov H.
    Arch Dis Child; 1990 Jun 25; 65(6):594-7. PubMed ID: 2198848
    [Abstract] [Full Text] [Related]

  • 11. Malabsorption in cystic fibrosis: mechanisms and treatment.
    Bouquet J, Sinaasappel M, Neijens HJ.
    J Pediatr Gastroenterol Nutr; 1988 Jun 25; 7 Suppl 1():S30-5. PubMed ID: 3404359
    [Abstract] [Full Text] [Related]

  • 12. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis.
    Santini B, Antonelli M, Battistini A, Bertasi S, Collura M, Esposito I, Di Febbraro L, Ferrari R, Ferrero L, Iapichino L, Lucidi V, Manca A, Pisconti CL, Pisi G, Raia V, Romano L, Rosati P, Grazioli I, Melzi G.
    Dig Liver Dis; 2000 Jun 25; 32(5):406-11. PubMed ID: 11030186
    [Abstract] [Full Text] [Related]

  • 13. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH, Heijerman HG, Geus WP, Bakker W, Lamers CB.
    Aliment Pharmacol Ther; 1994 Dec 25; 8(6):603-7. PubMed ID: 7696449
    [Abstract] [Full Text] [Related]

  • 14. Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations.
    Walters MP, Littlewood JM.
    J Pediatr Gastroenterol Nutr; 1998 Sep 25; 27(3):296-300. PubMed ID: 9740200
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis.
    Zentler-Munro PL, Assoufi BA, Balasubramanian K, Cornell S, Benoliel D, Northfield TC, Hodson ME.
    Pancreas; 1992 Sep 25; 7(3):311-9. PubMed ID: 1594552
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis.
    Chazalette JP, Dain MP, Castaigne JP.
    J Pediatr Gastroenterol Nutr; 1988 Sep 25; 7 Suppl 1():S46-8. PubMed ID: 3042939
    [Abstract] [Full Text] [Related]

  • 18. In Vitro Comparison of Physical Parameters, Enzyme Activity, Acid Resistance, and pH Dissolution Characteristics of Enteric-Coated Pancreatic Enzyme Preparations: Implications for Clinical Variability and Pharmacy Substitution.
    Kuhn RJ, Eyting S, Henniges F, Potthoff A.
    J Pediatr Pharmacol Ther; 2007 Apr 25; 12(2):115-28. PubMed ID: 23055848
    [Abstract] [Full Text] [Related]

  • 19. Solubility of oral pancreatic enzyme supplement capsules in biological fluids.
    Robb TS, Davidson GP, Cooper DM.
    Lancet; 1980 Sep 06; 2(8193):544. PubMed ID: 6105599
    [No Abstract] [Full Text] [Related]

  • 20. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK, Rubin J, Harvey J.
    Gastroenterology; 1983 Mar 06; 84(3):476-82. PubMed ID: 6549746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.